We are live on ! Find out more
BCAB icon

BioAtla
BCAB

53 hedge funds and large institutions have $530M invested in BioAtla in 2020 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.97% more ownership

Funds ownership: 0% → 0.97% (+0.97%)

Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Soleus Capital Management
Connecticut
+$106M
2
CAM
Cormorant Asset Management
Massachusetts
+$76.6M
3
FCM
Farallon Capital Management
California
+$65.8M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$59.5M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$44M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Soleus Capital Management
Connecticut
$108M +$106M +63,587 New
CAM
2
Cormorant Asset Management
Massachusetts
$75.4M +$76.6M +45,841 New
FCM
3
Farallon Capital Management
California
$66.9M +$65.8M +39,341 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$60.5M +$59.5M +35,602 New
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$44.8M +$44M +26,324 New
BBA
6
Baker Bros. Advisors
New York
$28.1M +$27.6M +16,500 New
BC
7
Boxer Capital
California
$23.3M +$22.9M +13,727 New
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$21.7M +$21.3M +12,770 New
Wellington Management Group
9
Wellington Management Group
Massachusetts
$20.3M +$19.9M +11,935 New
Massachusetts Financial Services
10
Massachusetts Financial Services
Massachusetts
$17M +$16.7M +9,997 New
Millennium Management
11
Millennium Management
New York
$11.1M +$10.9M +6,543 New
DM
12
Deerfield Management
New York
$9.54M +$9.37M +5,608 New
Citadel Advisors
13
Citadel Advisors
Florida
$6.3M +$6.19M +3,706 New
BlackRock
14
BlackRock
New York
$4.99M +$4.91M +2,937 New
Goldman Sachs
15
Goldman Sachs
New York
$3.57M +$3.51M +2,100 New
VA
16
VR Adviser
New York
$3.4M +$3.34M +2,000 New
PVI
17
Pura Vida Investments
New York
$2.6M +$2.55M +1,526 New
Vanguard Group
18
Vanguard Group
Pennsylvania
$2.55M +$2.51M +1,500 New
CCM
19
CAAS Capital Management
New York
$2.38M +$2.34M +1,400 New
PIM
20
Platinum Investment Management
Australia
$2.38M +$2.34M +1,400 New
APM
21
Avidity Partners Management
Texas
$1.7M +$1.67M +1,000 New
EC
22
EcoR1 Capital
California
$1.7M +$1.67M +1,000 New
SFM
23
Sphera Funds Management
Israel
$1.7M +$1.67M +1,000 New
Alyeska Investment Group
24
Alyeska Investment Group
Illinois
$1.36M +$1.34M +800 New
MWNA
25
Marshall Wace North America
New York
$1.05M +$1.03M +618 New
1
2 3

BCAB Hedge Fund Activity: Q4 2020 in Review

53 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q4 2020, worth a combined $530M.

Buyers outnumbered sellers: 53 funds opened new BCAB positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $106M.

  • 53 institutional investors held BioAtla (BCAB) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $530M of BioAtla stock for Q4 2020.
  • 53 funds opened new BioAtla positions in Q4 2020 and 0 closed out, a net change of +53 holders.
  • The largest BioAtla buyer in Q4 2020 was Soleus Capital Management, an estimated $106M added.

Based on aggregated 13F filings for Q4 2020.